Spinal muscular atrophy drug blocked in UK

By Ella Pickover
Updated August 14 2018 - 12:16pm, first published 12:13pm
Muscular atrophy sufferer Avery Ball, two, would benefit from a drug that's been rejected in the UK.
Muscular atrophy sufferer Avery Ball, two, would benefit from a drug that's been rejected in the UK.

A decision by UK health officials to reject a drug that treats a rare genetic disorder which can mean affected children do not live to their second birthday has been condemned by a charity.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Leeton news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.